Jūratė Savickienė

853 total citations
49 papers, 621 citations indexed

About

Jūratė Savickienė is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Jūratė Savickienė has authored 49 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 12 papers in Hematology and 8 papers in Cancer Research. Recurrent topics in Jūratė Savickienė's work include Retinoids in leukemia and cellular processes (18 papers), Histone Deacetylase Inhibitors Research (11 papers) and Acute Myeloid Leukemia Research (11 papers). Jūratė Savickienė is often cited by papers focused on Retinoids in leukemia and cellular processes (18 papers), Histone Deacetylase Inhibitors Research (11 papers) and Acute Myeloid Leukemia Research (11 papers). Jūratė Savickienė collaborates with scholars based in Lithuania, Sweden and Canada. Jūratė Savickienė's co-authors include Gražina Treigytė, Rūta Navakauskienė, Karl‐Eric Magnusson, Arūnas Gineitis, Gediminas Cepinskas, Peter R. Kvietys, Astrida Miceikienė, Torgny Stigbrand, Veronika Borutinskaitė and Algirdas Kaupinis and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Cell Biology and Annals of the New York Academy of Sciences.

In The Last Decade

Jūratė Savickienė

43 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jūratė Savickienė Lithuania 15 390 126 95 73 61 49 621
Bárbara Du Rocher Brazil 12 285 0.7× 150 1.2× 82 0.9× 62 0.8× 80 1.3× 19 496
Ivan Muradore Italy 9 533 1.4× 111 0.9× 58 0.6× 119 1.6× 118 1.9× 10 784
Mariana Lazarini Brazil 15 360 0.9× 48 0.4× 27 0.3× 106 1.5× 90 1.5× 42 567
Christina Wunrau Germany 6 339 0.9× 61 0.5× 35 0.4× 104 1.4× 101 1.7× 12 777
Zsolt Szíjgyártó United Kingdom 12 465 1.2× 137 1.1× 84 0.9× 21 0.3× 86 1.4× 24 866
Takeshi Ariyama Japan 14 428 1.1× 55 0.4× 42 0.4× 74 1.0× 99 1.6× 29 708
Kwesi Teye Japan 19 396 1.0× 426 3.4× 28 0.3× 109 1.5× 73 1.2× 59 1.2k
Keisuke Sakurada Japan 15 239 0.6× 82 0.7× 33 0.3× 243 3.3× 25 0.4× 54 627
Lingbo Zhang China 14 398 1.0× 132 1.0× 59 0.6× 162 2.2× 163 2.7× 27 894
Diha Freije United States 14 792 2.0× 30 0.2× 85 0.9× 36 0.5× 231 3.8× 19 1.2k

Countries citing papers authored by Jūratė Savickienė

Since Specialization
Citations

This map shows the geographic impact of Jūratė Savickienė's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jūratė Savickienė with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jūratė Savickienė more than expected).

Fields of papers citing papers by Jūratė Savickienė

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jūratė Savickienė. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jūratė Savickienė. The network helps show where Jūratė Savickienė may publish in the future.

Co-authorship network of co-authors of Jūratė Savickienė

This figure shows the co-authorship network connecting the top 25 collaborators of Jūratė Savickienė. A scholar is included among the top collaborators of Jūratė Savickienė based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jūratė Savickienė. Jūratė Savickienė is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Savickienė, Jūratė, et al.. (2024). The Role of Innovation Activity in Sustainable Development. SHILAP Revista de lepidopterología. 574. 2009–2009.
3.
Treigytė, Gražina, et al.. (2019). Epigenetic regulation of amniotic fluid mesenchymal stem cell differentiation to the mesodermal lineages at normal and fetus‐diseased gestation. Journal of Cellular Biochemistry. 121(2). 1811–1822. 7 indexed citations
4.
Savickienė, Jūratė & Astrida Miceikienė. (2018). Sustainable economic development assessment model for family farms. Agricultural Economics (Zemědělská ekonomika). 64(12). 527–535. 20 indexed citations
5.
Miceikienė, Astrida, et al.. (2017). ŽEMĖS ŪKIO KOOPERATYVŲ FINANSAVIMO GALIMYBĖS IR PROBLEMOS. 11(1). 32–40. 2 indexed citations
6.
Savickienė, Jūratė, et al.. (2017). Histone Modifications Pattern Associated With a State of Mesenchymal Stem Cell Cultures Derived From Amniotic Fluid of Normal and Fetus‐Affected Gestations. Journal of Cellular Biochemistry. 118(11). 3744–3755. 3 indexed citations
7.
Treigytė, Gražina, et al.. (2016). Histone modifications patterns in tissues and tumours from acute promyelocytic leukemia xenograft model in response to combined epigenetic therapy. Biomedicine & Pharmacotherapy. 79. 62–70. 10 indexed citations
8.
Savickienė, Jūratė, et al.. (2014). COMPARATIVE ANALYSIS OF FARM ECONOMIC VIABILITY ASSESSMENT METHODOLOGIES. European Scientific Journal ESJ. 10(7). 11 indexed citations
9.
Savickienė, Jūratė, et al.. (2013). Assessment of the Principles of Family Holding Taxation. 7(1). 86–100. 1 indexed citations
10.
Savickienė, Jūratė, et al.. (2012). Ūkių ekonominį gyvybingumą lemiančių veiksnių vertinimas Lietuvos ūkininkų ūkių pavyzdžiu. 19(1). 4 indexed citations
11.
Savickienė, Jūratė, et al.. (2010). Low-dose ionizing radiation effects on differentiation of HL-60 cells. Open Life Sciences. 5(5). 600–612. 4 indexed citations
12.
13.
Savickienė, Jūratė, et al.. (2010). Mokesčių lengvatų taikymo žemės ūkyje vertinimas. 179–185. 1 indexed citations
14.
Savickienė, Jūratė, Gražina Treigytė, Arūnas Gineitis, & Rūta Navakauskienė. (2010). A critical role of redox state in determining HL-60 cell granulocytic differentiation and apoptosis via involvement of PKC and NF-κB. In Vitro Cellular & Developmental Biology - Animal. 46(6). 547–559. 3 indexed citations
15.
Pivoriūnas, Augustas, Veronika Borutinskaitė, Gražina Treigytė, et al.. (2009). Proteomic Analysis of Stromal Cells Derived from the Dental Pulp of Human Exfoliated Deciduous Teeth. Stem Cells and Development. 19(7). 1081–1093. 61 indexed citations
17.
Savickienė, Jūratė, et al.. (2006). The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines. European Journal of Pharmacology. 549(1-3). 9–18. 36 indexed citations
18.
Savickienė, Jūratė & Arūnas Gineitis. (2003). 3-Deazauridine triggers dose-dependent apoptosis in myeloid leukemia cells and enhances retinoic acid-induced granulocytic differentiation of HL-60 cells. The International Journal of Biochemistry & Cell Biology. 35(10). 1482–1494. 6 indexed citations
19.
Cepinskas, Gediminas, et al.. (2003). Neutrophils Induce Sequential Focal Changes in Endothelial Adherens Junction Components: Role of Elastase. Microcirculation. 10(2). 205–220. 31 indexed citations
20.
Savickienė, Jūratė, et al.. (1995). Protein kinase inhibitors exert stage specific and inducer dependent effects on HL-60 cell differentiation.. PubMed. 15(3). 687–92. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026